Listing in London – King & Spalding carries US biotech to AIM listing Legal Business11 May 2015Corporate and M&AUS King & Spalding’s recent recruits in the City have helped handle Californian biotech company Verseon £300m stock market listing in London while Covington & Burling advised from San Francisco.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categorySidley London partner promotions up despite smaller global round‘There’s definitely competition around rates’ – Clifford Chance and Linklaters match Cravath bonuses for US associates‘This was not a good idea and we’re entitled to say so’ – LLP tax proposals get short shrift‘History in the making’ – Hogan Lovells set for record $3.6bn merger with CadwaladerRevolving Doors: Latham swipes German transactions team from Freshfields as Ropes rebuilds in private equity‘A merger of complementaries’ or ‘transatlantic panic’? – the market view on Winston TaylorClifford Chance names Cohen first New York managing partner amid fresh bid to crack America with Houston office openingInternational Women’s Day 2022: Barbara L. Becker, chair & managing partner, Gibson Dunn, New YorkInternational Women’s Day 2022: Perlette Jura, Gibson Dunn, Los Angeles – disputes